◆英語タイトル:SurgaColl Technologies Ltd - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010094
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaColl Technologies’s hydroxycoll is a bone graft substitute that helps the body to create, own natural healing process from bioactive materials. The company’s hydroxycoll scaffold is a bioactive and biodegradable matrix that is optimized to facilitate and promote bone tissue healing. It operates in Bishopstown and Dublin. SurgaColl Technologies is headquartered in Dublin, Ireland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SurgaColl Technologies Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
SurgaColl Technologies Ltd Company Overview 4
SurgaColl Technologies Ltd Company Snapshot 4
SurgaColl Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
SurgaColl Technologies Ltd – Pipeline Analysis Overview 7
SurgaColl Technologies Ltd – Key Facts 7
SurgaColl Technologies Ltd – Major Products and Services 8
SurgaColl Technologies Ltd Pipeline Products by Development Stage 9
SurgaColl Technologies Ltd Pipeline Products Overview 11
CardioColl 11
CardioColl Product Overview 11
ChondroColl 12
ChondroColl Product Overview 12
DentaColl 13
DentaColl Product Overview 13
SurgaColl Technologies Ltd – Key Competitors 14
SurgaColl Technologies Ltd – Key Employees 15
SurgaColl Technologies Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
SurgaColl Technologies Ltd, Recent Developments 17
Jan 16, 2017: SurgaColl Technologies: Board Announcement – Appointment of CEO 17
Jan 20, 2015: Launch of world first bone repair technology marks successful first year for AMBER 17
Appendix 18
Methodology 18
About GlobalData 20
Contact Us 20
Disclaimer 21
List of Tables
SurgaColl Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
SurgaColl Technologies Ltd Pipeline Products by Equipment Type 5
SurgaColl Technologies Ltd Pipeline Products by Indication 6
SurgaColl Technologies Ltd, Key Facts 7
SurgaColl Technologies Ltd, Major Products and Services 8
SurgaColl Technologies Ltd Number of Pipeline Products by Development Stage 9
SurgaColl Technologies Ltd Pipeline Products Summary by Development Stage 10
CardioColl - Product Status 11
CardioColl - Product Description 11
ChondroColl - Product Status 12
ChondroColl - Product Description 12
DentaColl - Product Status 13
DentaColl - Product Description 13
SurgaColl Technologies Ltd, Key Employees 15
SurgaColl Technologies Ltd, Other Locations 16
Glossary 19